Form 8-K for BLUEBIRD BIO, INC.
Other Events, Financial Statements and Exhibits
Item 8.01Other EventsOn June 22, 2015, bluebird bio, Inc. (“bluebird”), and Kite Pharma, Inc. (“Kite”) issued a joint press release announcing that they have entered into a collaboration agreement to advance second generation T cell receptor product candidates to treat certain cancers associated with human papillomavirus. The full text of the press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release issued by bluebird bio, Inc. and Kite Pharma, Inc. on June 22, 2015